PROCYON CORP (PCYN)

↓ Download CSV

CIK 0000812306 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated CO
  • Fiscal year ends Jun 30

In fiscal 2024, PROCYON CORP reported revenue of $4.98M, up 6.4% from the prior year. The company ran a net loss, with a net margin of -6.8% and a gross margin of 78.1%. It held $3.20M in total assets against $917.1K in total liabilities.

Key ratios (FY2024)

78.1%
Gross margin
-4.6%
Operating margin
-6.8%
Net margin
-14.9%
Return on equity
+6.4%
Revenue growth (YoY)
Metric (FY)2024202320222021202020192018201720162015
Revenue$4.98M$4.69M$4.84M$4.72M$4.33M$4.19M$4.02M$4.01M$3.45M$2.77M
Cost of Revenue$1.09M$1.12M$1.36M$1.33M$1.13M$1.14M$1.08M$1.26M
Gross Profit$3.89M$3.57M$3.49M$3.39M$3.20M$3.05M$2.94M$2.75M$2.42M$1.96M
Operating Income-$231.7K-$97.4K-$237.2K$226.7K$153.0K$97.1K$127.1K$30.0K-$103.6K-$341.4K
Net Income-$341.1K-$50.2K-$209.8K$694.3K$111.7K$27.2K-$255.7K$12.4K$109.6K
EPS (Diluted)$-0.04$-0.01$-0.03$0.08$0.01$0.00$-0.03$0.00$0.01$-0.03
Total Assets$3.20M$3.56M$3.80M$4.27M$2.82M$2.43M$2.36M$2.73M$3.12M$2.52M
Total Liabilities$917.1K$946.0K$1.13M$1.39M$657.9K$375.9K$326.5K$442.3K$848.6K
Shareholders' Equity$2.29M$2.35M$2.64M$2.85M$2.46M$2.14M$2.05M$1.92M$2.27M$2.16M
Cash & Equivalents$290.3K$270.3K$173.2K$59.2K$204.2K
Operating Cash Flow-$61.3K$145.5K-$383.5K$279.5K$198.8K$50.8K$86.5K$199.6K$18.7K-$392.0K
Capital Expenditures$63.9K$180.1K$82.6K$65.2K$23.0K$28.8K$46.7K$18.9K$73.3K$66.5K
Shares Outstanding8.12M8.09M8.09M8.09M8.09M8.09M8.08M8.08M8.06M8.06M